Our results demonstrate that Hu19-CD828z CAR T-cells exhibit CAR-mediated, CD19-dependent activity against autologous B-cells, with comparably low inflammatory cytokine production when derived from cells from SLE, IIM, and SSc patients and healthy donors. The gene discussed is CD19; the disease is systemic sclerosis.